Combined CAR-T Congress Europe

View Full Event Details

The event aims to bring together thought leaders from biotech, big pharma, academia, and the wider service community to address the challenges and opportunities of CAR-T therapies—including CAR-T, CAR-Tregs and combined therapies—that are critical to furthering the development of viable T-cell therapies. Exploring ground-breaking developments in this fast growing field, the event want to provide the opportunity to collaborate to create a commercially viable, effective, and safe therapy.


  • Advancements in CAR-T manufacturing and automation
  • A combined approach to cell therapy
  • Results from unpublished human and clinical studies
  • Commercialisation of CAR-T therapies
  • Improving the safety of CAR-T through safety switches
  • Exploring the tumour microenvironment for therapy targets and improvements
  • The potential of CAR-Tregs in autoimmunity


Article Views: 339

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from, please contact us first for permission. more

CONNECT: on Facebook on Twitter on YouTube on LinkedIn Sign up for our free newsletter

A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH